Treace_color.jpg
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
December 16, 2024 08:30 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
December 04, 2024 16:15 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Appoints Guy Guglielmino as Chief Commercial Officer
December 02, 2024 16:15 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Announces Participation at Stifel 2024 Healthcare Conference
November 18, 2024 16:46 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
November 05, 2024 16:05 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Announces Participation in the UBS Global Healthcare Conference
November 04, 2024 17:29 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
November 04, 2024 08:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
November 04, 2024 07:00 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
October 22, 2024 16:30 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace_color.jpg
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
October 14, 2024 09:45 ET | Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...